Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.66%40.93M | 0.96%167.94M | 15.64%44.33M | -1.14%41.28M | -4.43%42.07M | -4.69%40.26M | -17.86%166.35M | -20.46%38.33M | -20.66%41.76M | -12.66%44.02M |
Net interest income | 2.90%31.47M | -1.27%125.65M | 7.19%31.83M | 2.62%31.89M | -2.34%31.35M | -11.09%30.58M | -14.58%127.27M | -24.23%29.69M | -20.98%31.08M | -13.70%32.1M |
-Net interest income | -3.68%64.44M | 11.10%271.41M | 4.87%67.52M | 9.29%69.03M | 11.76%67.95M | 19.60%66.9M | 42.09%244.29M | 24.02%64.39M | 41.76%63.16M | 52.55%60.8M |
-Interest income from loans and lease | -0.02%60.17M | 9.62%249.11M | 5.12%62.93M | 9.65%64.14M | 10.80%61.86M | 13.43%60.18M | 38.87%227.25M | 20.92%59.87M | 37.82%58.49M | 47.49%55.83M |
-Interest income from securities | -3.49%1.99M | 0.36%8.15M | -0.25%2M | -1.90%1.97M | 4.23%2.12M | -0.67%2.07M | 6.96%8.12M | -2.15%2M | 1.62%2M | 8.65%2.04M |
-Other interest income | -51.11%2.28M | 58.60%14.15M | 2.98%2.59M | 9.79%2.93M | 35.30%3.97M | 480.20%4.66M | 1,185.45%8.92M | 600.84%2.52M | 1,765.03%2.67M | 2,140.46%2.94M |
-Total interest expense | -9.23%32.97M | 24.56%145.76M | 2.88%35.69M | 15.76%37.14M | 27.53%36.6M | 68.62%36.32M | 410.01%117.02M | 172.61%34.69M | 514.17%32.08M | 978.14%28.7M |
-Interest expense for deposit | 2.77%27.64M | 29.19%114.1M | 9.71%29.96M | 19.69%29.97M | 35.94%27.27M | 69.04%26.9M | 465.09%88.32M | 221.33%27.31M | 617.24%25.04M | 893.66%20.06M |
-Interest expense for long term debt and capital securities | -43.47%5.33M | 10.32%31.65M | -22.39%5.73M | 1.80%7.17M | 8.00%9.33M | 67.43%9.42M | 292.30%28.69M | 74.64%7.38M | 306.52%7.05M | 1,243.39%8.64M |
Non interest income | -2.27%9.46M | 8.21%42.29M | 44.70%12.5M | -12.08%9.39M | -10.07%10.72M | 23.42%9.68M | -27.02%39.08M | -4.02%8.64M | -19.72%10.68M | -9.74%11.92M |
-Total premiums earned | -0.40%743K | 10.95%3.05M | -36.29%769K | 46.33%777K | 48.34%758K | 49.20%746K | 38.77%2.75M | 140.92%1.21M | 5.57%531K | 3.44%511K |
-Fees and commissions | -12.70%5.46M | 1.82%22.72M | 69.37%7.25M | -40.38%3.94M | -24.74%5.28M | 41.77%6.25M | -28.42%22.32M | 1.42%4.28M | -19.37%6.61M | -6.04%7.02M |
-Other non interest income | -18.83%543K | -19.99%2.89M | -45.55%532K | 10.18%920K | -29.51%769K | -5.64%669K | -18.28%3.61M | -50.66%977K | 5.16%835K | 54.75%1.09M |
-Gain loss on sale of assets | 34.92%2.72M | 30.99%13.63M | 81.62%3.95M | 38.76%3.75M | 18.52%3.91M | -9.49%2.01M | -34.85%10.4M | -5.43%2.18M | -29.01%2.7M | -27.28%3.3M |
Credit losses provision | -924.40%-1.39M | -45.72%-8.28M | -199.22%-1.93M | -5,323.89%-5.9M | 81.27%-615K | 109.00%168K | -0.35%-5.68M | 69.45%-644K | 116.92%113K | -28.95%-3.28M |
Non interest expense | 5.64%32.42M | 0.50%125.41M | -1.57%31.69M | 0.44%31.09M | 3.11%31.94M | 0.09%30.69M | -7.66%124.79M | -4.61%32.19M | -7.69%30.95M | -9.03%30.98M |
Occupancy and equipment | -3.22%4.63M | -1.34%18.52M | -4.13%4.48M | 4.47%4.63M | 0.06%4.64M | -5.14%4.78M | -5.03%18.77M | -5.37%4.67M | -8.26%4.43M | 1.27%4.63M |
Professional expense and contract services expense | -5.15%1.38M | -4.28%5.44M | -14.14%1.45M | -5.97%1.29M | 10.95%1.24M | -2.93%1.46M | -7.24%5.68M | 16.87%1.69M | -5.70%1.37M | -33.69%1.11M |
Selling and administrative expenses | 4.11%20.42M | 0.72%81.7M | -0.91%20.62M | -1.80%20.13M | 5.00%21.34M | 0.65%19.62M | -8.49%81.11M | -2.56%20.81M | -7.66%20.5M | -10.85%20.32M |
-General and administrative expense | 5.51%19.84M | 1.24%78.36M | 0.11%20.02M | -0.63%19.58M | 2.95%19.97M | 2.68%18.8M | -8.64%77.4M | -2.42%19.99M | -7.71%19.7M | -11.06%19.4M |
-Selling and marketing expense | -27.94%588K | -10.21%3.33M | -26.14%599K | -30.86%549K | 47.89%1.37M | -30.91%816K | -5.23%3.71M | -5.92%811K | -6.59%794K | -6.19%925K |
Other non-interest expense | 23.83%5.99M | 2.77%19.75M | 2.35%5.14M | 8.36%5.04M | -3.64%4.74M | 4.41%4.84M | -6.78%19.22M | -16.44%5.03M | -7.83%4.65M | -1.84%4.91M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -10.76M | ||||||||
Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | --10.76M | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | -26.86%7.13M | 36.35%34.26M | 303.69%10.72M | -60.71%4.29M | -2.50%9.51M | 0.29%9.74M | -59.30%25.13M | -142.64%-5.26M | -40.77%10.92M | -29.31%9.75M |
Income tax | -33.43%1.63M | -24.29%6.85M | -1.14%1.83M | -85.40%366K | -2.68%2.21M | 1.03%2.44M | -43.94%9.05M | -32.97%1.85M | -46.41%2.51M | -40.30%2.28M |
Earnings from equity interest net of tax | ||||||||||
Net income | -24.66%5.5M | 70.47%27.41M | 224.98%8.89M | -53.35%3.92M | -2.45%7.3M | 0.04%7.3M | -64.73%16.08M | -174.25%-7.11M | -38.86%8.41M | -25.11%7.48M |
Net Income continuous operations | -24.66%5.5M | 70.47%27.41M | 224.98%8.89M | -53.35%3.92M | -2.45%7.3M | 0.04%7.3M | -64.73%16.08M | -174.25%-7.11M | -38.86%8.41M | -25.11%7.48M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -24.66%5.5M | 70.47%27.41M | 224.98%8.89M | -53.35%3.92M | -2.45%7.3M | 0.04%7.3M | -64.73%16.08M | -174.25%-7.11M | -38.86%8.41M | -25.11%7.48M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -24.66%5.5M | 70.47%27.41M | 224.98%8.89M | -53.35%3.92M | -2.45%7.3M | 0.04%7.3M | -64.73%16.08M | -174.25%-7.11M | -38.86%8.41M | -25.11%7.48M |
Basic earnings per share | -17.65%0.14 | 78.38%0.66 | 223.53%0.21 | -50.00%0.1 | 5.88%0.18 | 6.25%0.17 | -62.24%0.37 | -180.95%-0.17 | -33.33%0.2 | -19.05%0.17 |
Diluted earnings per share | -17.65%0.14 | 78.38%0.66 | 223.53%0.21 | -50.00%0.1 | 5.88%0.18 | 6.25%0.17 | -61.86%0.37 | -180.95%-0.17 | -33.33%0.2 | -19.05%0.17 |
Dividend per share | 6.67%0.08 | 6.78%0.315 | 6.67%0.08 | 6.67%0.08 | 6.67%0.08 | 7.14%0.075 | 13.46%0.295 | 7.14%0.075 | 7.14%0.075 | 7.14%0.075 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |